Role of Platelet/Lymphocyte, Neutrophil/Lymphocyte, and Interleukin-37/Interleukin-17 Ratios in the Occurrence and Treatment of Rheumatoid Arthritis.

MLA

Meng, Yan, et al. “Role of Platelet/Lymphocyte, Neutrophil/Lymphocyte, and Interleukin-37/Interleukin-17 Ratios in the Occurrence and Treatment of Rheumatoid Arthritis.” Immunological Investigations, vol. 53, no. 3, Apr. 2024, pp. 464–74. EBSCOhost, https://doi.org/10.1080/08820139.2023.2299687.

APA

Meng, Y., Cai, X.-L., Cong, S., Sun, J., Hu, Y.-W., Gu, Y.-Q., Ma, X.-M., & Luo, L. (2024). Role of Platelet/Lymphocyte, Neutrophil/Lymphocyte, and Interleukin-37/Interleukin-17 Ratios in the Occurrence and Treatment of Rheumatoid Arthritis. Immunological Investigations, 53(3), 464–474. https://doi.org/10.1080/08820139.2023.2299687

Chicago

Meng, Yan, Xuan-Lin Cai, Shan Cong, Jiao Sun, Yong-Wei Hu, Yan-Qin Gu, Xiu-Min Ma, and Li Luo. 2024. “Role of Platelet/Lymphocyte, Neutrophil/Lymphocyte, and Interleukin-37/Interleukin-17 Ratios in the Occurrence and Treatment of Rheumatoid Arthritis.” Immunological Investigations 53 (3): 464–74. doi:10.1080/08820139.2023.2299687.